Assyro AI

FDA Orange Book · active-ingredient family

Acetaminophen; butalbital; caffeine; codeine phosphate

Acetaminophen; butalbital; caffeine; codeine phosphate is approved as 1 brand and 7 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:FIORICET W/ CODEINE · NDA 020232

1

Brand (NDA)

7

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · capsule

ProductApplicantApplicationTEApproved
FIORICET W/ CODEINERLDACTAVIS LABS UT INCNDA 020232ABJul 30, 1992

Generic (ANDA) products (7)

ProductApplicantApplicationTEApproved
BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE×2HIKMAANDA 215138ABJan 26, 2022
BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATEQUAGENANDA 204649Jul 08, 2020
BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE×2LGM PHARMAANDA 076560ABJul 19, 2012
BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATEABLEANDA 076528Aug 21, 2003
BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATEPHARMOBEDIENTANDA 075929Apr 22, 2002
PHRENILIN WITH CAFFEINE AND CODEINEVALEANTANDA 074911Aug 22, 2001
BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATEHIKMA INTL PHARMSANDA 075618Mar 23, 2001

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Acetaminophen; butalbital; caffeine; codeine phosphate — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.